vs
Side-by-side financial comparison of AdvanSix Inc. (ASIX) and Climb Global Solutions, Inc. (CLMB). Click either name above to swap in a different company.
AdvanSix Inc. is the larger business by last-quarter revenue ($359.9M vs $182.4M, roughly 2.0× Climb Global Solutions, Inc.). Climb Global Solutions, Inc. runs the higher net margin — 1.8% vs -0.8%, a 2.6% gap on every dollar of revenue. On growth, Climb Global Solutions, Inc. posted the faster year-over-year revenue change (32.1% vs 9.4%). Over the past eight quarters, Climb Global Solutions, Inc.'s revenue compounded faster (40.7% CAGR vs 3.4%).
AdvanSix Inc. is an American chemical company that produces nylon 6 and related chemicals such as caprolactam and ammonium sulfate fertilizers. It operated as Honeywell's Resins and Chemicals division until 2016, when it was spun off as a separate company. The unit accounted for 3 percent of Honeywell's sales at the time. For 2019, revenue is estimated at $1.4 billion. The company traces its lineage to the H. W. Jayne Company, established 1884 in Frankford, Pennsylvania.
Univar Solutions Inc. is a global chemical and ingredients distributor and provider of value-added services.
ASIX vs CLMB — Head-to-Head
Income Statement — Q4 FY2025 vs Q1 FY2026
| Metric | ||
|---|---|---|
| Revenue | $359.9M | $182.4M |
| Net Profit | $-2.8M | $3.3M |
| Gross Margin | 7.6% | 14.5% |
| Operating Margin | -0.7% | 2.1% |
| Net Margin | -0.8% | 1.8% |
| Revenue YoY | 9.4% | 32.1% |
| Net Profit YoY | -892.9% | -9.5% |
| EPS (diluted) | $-0.11 | $0.18 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | — | $182.4M | ||
| Q4 25 | $359.9M | $193.8M | ||
| Q3 25 | $374.5M | $161.3M | ||
| Q2 25 | $410.0M | $159.3M | ||
| Q1 25 | $377.8M | $138.0M | ||
| Q4 24 | $329.1M | $161.8M | ||
| Q3 24 | $398.2M | $119.3M | ||
| Q2 24 | $453.5M | $92.1M |
| Q1 26 | — | $3.3M | ||
| Q4 25 | $-2.8M | $7.0M | ||
| Q3 25 | $-2.6M | $4.7M | ||
| Q2 25 | $31.4M | $6.0M | ||
| Q1 25 | $23.3M | $3.7M | ||
| Q4 24 | $352.0K | $7.0M | ||
| Q3 24 | $22.3M | $5.5M | ||
| Q2 24 | $38.9M | $3.4M |
| Q1 26 | — | 14.5% | ||
| Q4 25 | 7.6% | 15.4% | ||
| Q3 25 | 6.8% | 15.9% | ||
| Q2 25 | 14.3% | 16.5% | ||
| Q1 25 | 14.2% | 16.9% | ||
| Q4 24 | 3.4% | 19.3% | ||
| Q3 24 | 14.4% | 20.3% | ||
| Q2 24 | 17.9% | 20.2% |
| Q1 26 | — | 2.1% | ||
| Q4 25 | -0.7% | 4.9% | ||
| Q3 25 | -0.9% | 4.3% | ||
| Q2 25 | 7.7% | 5.0% | ||
| Q1 25 | 7.7% | 3.5% | ||
| Q4 24 | -3.9% | 7.2% | ||
| Q3 24 | 7.5% | 7.1% | ||
| Q2 24 | 11.5% | 4.6% |
| Q1 26 | — | 1.8% | ||
| Q4 25 | -0.8% | 3.6% | ||
| Q3 25 | -0.7% | 2.9% | ||
| Q2 25 | 7.7% | 3.7% | ||
| Q1 25 | 6.2% | 2.7% | ||
| Q4 24 | 0.1% | 4.3% | ||
| Q3 24 | 5.6% | 4.6% | ||
| Q2 24 | 8.6% | 3.7% |
| Q1 26 | — | $0.18 | ||
| Q4 25 | $-0.11 | $1.51 | ||
| Q3 25 | $-0.10 | $1.02 | ||
| Q2 25 | $1.15 | $1.30 | ||
| Q1 25 | $0.86 | $0.81 | ||
| Q4 24 | $0.02 | $1.52 | ||
| Q3 24 | $0.82 | $1.19 | ||
| Q2 24 | $1.43 | $0.75 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | ||
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $19.8M | $41.8M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $815.2M | $118.4M |
| Total Assets | $1.7B | $458.8M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | $41.8M | ||
| Q4 25 | $19.8M | $36.6M | ||
| Q3 25 | $23.7M | $49.8M | ||
| Q2 25 | $18.4M | $28.6M | ||
| Q1 25 | $8.3M | $32.5M | ||
| Q4 24 | $19.6M | $29.8M | ||
| Q3 24 | $17.3M | $22.1M | ||
| Q2 24 | $12.1M | $48.4M |
| Q1 26 | — | $118.4M | ||
| Q4 25 | $815.2M | $116.6M | ||
| Q3 25 | $818.2M | $109.3M | ||
| Q2 25 | $823.7M | $105.2M | ||
| Q1 25 | $794.4M | $95.6M | ||
| Q4 24 | $774.6M | $90.6M | ||
| Q3 24 | $766.4M | $87.7M | ||
| Q2 24 | $746.6M | $79.8M |
| Q1 26 | — | $458.8M | ||
| Q4 25 | $1.7B | $460.2M | ||
| Q3 25 | $1.7B | $376.1M | ||
| Q2 25 | $1.6B | $420.7M | ||
| Q1 25 | $1.6B | $370.1M | ||
| Q4 24 | $1.6B | $469.2M | ||
| Q3 24 | $1.5B | $371.9M | ||
| Q2 24 | $1.5B | $302.8M |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | ||
|---|---|---|
| Operating Cash FlowLast quarter | $63.7M | — |
| Free Cash FlowOCF − Capex | $36.1M | — |
| FCF MarginFCF / Revenue | 10.0% | — |
| Capex IntensityCapex / Revenue | 7.7% | — |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | $6.4M | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | — | ||
| Q4 25 | $63.7M | $-11.9M | ||
| Q3 25 | $26.6M | $22.2M | ||
| Q2 25 | $21.1M | $-2.2M | ||
| Q1 25 | $11.4M | $8.5M | ||
| Q4 24 | $64.2M | $16.0M | ||
| Q3 24 | $57.3M | $-3.6M | ||
| Q2 24 | $50.2M | $7.3M |
| Q1 26 | — | — | ||
| Q4 25 | $36.1M | — | ||
| Q3 25 | $66.0K | — | ||
| Q2 25 | $-7.2M | — | ||
| Q1 25 | $-22.6M | — | ||
| Q4 24 | $29.8M | — | ||
| Q3 24 | $26.8M | — | ||
| Q2 24 | $16.7M | — |
| Q1 26 | — | — | ||
| Q4 25 | 10.0% | — | ||
| Q3 25 | 0.0% | — | ||
| Q2 25 | -1.7% | — | ||
| Q1 25 | -6.0% | — | ||
| Q4 24 | 9.1% | — | ||
| Q3 24 | 6.7% | — | ||
| Q2 24 | 3.7% | — |
| Q1 26 | — | — | ||
| Q4 25 | 7.7% | — | ||
| Q3 25 | 7.1% | — | ||
| Q2 25 | 6.9% | — | ||
| Q1 25 | 9.0% | — | ||
| Q4 24 | 10.4% | — | ||
| Q3 24 | 7.7% | — | ||
| Q2 24 | 7.4% | — |
| Q1 26 | — | — | ||
| Q4 25 | — | -1.70× | ||
| Q3 25 | — | 4.73× | ||
| Q2 25 | 0.67× | -0.37× | ||
| Q1 25 | 0.49× | 2.30× | ||
| Q4 24 | 182.29× | 2.29× | ||
| Q3 24 | 2.57× | -0.66× | ||
| Q2 24 | 1.29× | 2.13× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
ASIX
| Plant Nutrients | $140.0M | 39% |
| Chemical Intermediates | $92.8M | 26% |
| Caprolactam | $64.4M | 18% |
| Nylon Resins | $62.8M | 17% |
CLMB
Segment breakdown not available.